45 related articles for article (PubMed ID: 38587693)
1. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma.
Eskian M; Khorasanizadeh M; Isidori A; Rezaei N
Int J Hematol Oncol; 2018 Mar; 7(1):IJH01. PubMed ID: 30302233
[TBL] [Abstract][Full Text] [Related]
3. Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas.
Zhou S; Rao J; Ma X; Zeng Y; Xiang X; Li J; Liu H; Lin S; Dong S; Li F; Zhang X; Gao L
Int J Hematol; 2024 Apr; ():. PubMed ID: 38587693
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes.
Liu H; Zou H; Shan D; Liu W; Huang W; Sui W; Deng S; Wang T; Lv R; Fu M; Xu Y; Yi S; An G; Zhao Y; Qiu L; Zou D
Cancer Med; 2024 Jan; 13(2):e6965. PubMed ID: 38348996
[TBL] [Abstract][Full Text] [Related]
5. High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party.
Robinson SP; Boumendil A; Finel H; Dreger P; Sureda A; Hermine O; Montoto S
Bone Marrow Transplant; 2018 Dec; 53(12):1553-1559. PubMed ID: 29884850
[TBL] [Abstract][Full Text] [Related]
6. BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity.
Jo JC; Kang BW; Jang G; Sym SJ; Lee SS; Koo JE; Kim JW; Kim S; Huh J; Suh C
Ann Hematol; 2008 Jan; 87(1):43-8. PubMed ID: 17710401
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation.
Cohen YI; Lebel E; Zimran E; Shaulov A; Stepensky P; Grisariu S; Avni B
Transplant Cell Ther; 2023 Aug; 29(8):505.e1-505.e8. PubMed ID: 37160229
[TBL] [Abstract][Full Text] [Related]
8. Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges.
Razeghian E; Suksatan W; Sulaiman Rahman H; Bokov DO; Abdelbasset WK; Hassanzadeh A; Marofi F; Yazdanifar M; Jarahian M
Front Immunol; 2021; 12():699746. PubMed ID: 34489946
[TBL] [Abstract][Full Text] [Related]
9. A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high-risk or relapsed/refractory non-Hodgkin's lymphomas.
Ji J; Liu Z; Kuang P; Dong T; Chen X; Li J; Zhang C; Liu J; Zhang L; Shen K; Liu T
Int J Cancer; 2021 Dec; 149(12):2075-2082. PubMed ID: 34398971
[TBL] [Abstract][Full Text] [Related]
10. High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell Lymphoma.
Wen Q; Gao L; Xiong JK; Li Q; Wang SB; Wang JS; Liu F; Zhang C; Liu Y; Kong PY; Peng XG; Rao J; Gao L; Zhang X
Curr Med Sci; 2021 Jun; 41(3):465-473. PubMed ID: 34218355
[TBL] [Abstract][Full Text] [Related]
11. The nutrition risk index is associated with bacteremia within 30 days after autologous stem cell transplantation in patients with multiple myeloma.
Garzón Herazo JR; Muñoz Velandia OM; Solano JC; Molina Pimienta L; Figueroa Lemus WJ
Transpl Infect Dis; 2020 Aug; 22(4):e13302. PubMed ID: 32367601
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma.
Kim DY; Chung JS; Jo JC; Cho SH; Shin HJ
Ann Hematol; 2020 Apr; 99(4):819-828. PubMed ID: 32025840
[TBL] [Abstract][Full Text] [Related]
13. A Review of Autologous Stem Cell Transplantation in Lymphoma.
Zahid U; Akbar F; Amaraneni A; Husnain M; Chan O; Riaz IB; McBride A; Iftikhar A; Anwer F
Curr Hematol Malig Rep; 2017 Jun; 12(3):217-226. PubMed ID: 28478586
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity.
Shi Y; Liu P; Zhou S; Yang J; Han X; He X; Zhang C; Gui L; Qin Y; Yang S; Zhao L; Yao J; Jia B; Zhang S; Sun Y; Shi Y
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e423-e429. PubMed ID: 28101911
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
